Syntho Chirals Private Limited

Syntho Chirals Private Limited - pharma in Hyderabad, Telangana, India. FY 2026 financials & compliance.
CIN U24239TG2004PTC043066 Incorporated 15 April 2004 ROC Hyderabad HQ Hyderabad, Telangana, India
Active Private Limited Company pharma
Data last updated
Revenue · FY 2024
₹162.38 Cr
▲ 23% YoY
Net profit · FY 2024
₹25.52 Cr
Net margin 15.7%
EBITDA · FY 2024
₹37.66 Cr
EBITDA margin 23.2%
Authorised capital
₹9.7 Cr
Registered with MCA
Paid-up capital
₹9.7 Cr
Issued & subscribed
Open charges
₹26.91 Cr
Satisfied ₹32.03 Cr
Company age
22 yrs
Est. 2004
Employees · EPFO
41
Provident fund records

About Syntho Chirals Private Limited

Data last updated:

Syntho Chirals Private Limited is a private limited company based in Hyderabad, Telangana, India. It operates in the API manufacturers segment of the pharmaceuticals sector. It was incorporated on 15 April 2004 and has been in existence for over 22 years.

The company is registered with the Registrar of Companies (ROC), Hyderabad, under CIN U24239TG2004PTC043066. Its GSTIN is 36AAICS0868B1ZF (Telangana). The company holds 3 GST registrations, of which 2 are active.

The company has an authorised share capital of ₹9.7 Cr and a paid-up capital of ₹9.7 Cr. It is led by directors including Sai Kiran Reddy Ragi (Managing Director) and Cheemarla Vijaya Bhaskar Reddy.

Its last annual general meeting (AGM) was held on 30 September 2024, and its latest financial statements are for the year ended 31 March 2024. The registered office is at 66/B Phase – II Ida Mallapur, Hyderabad, Telangana, India – 500076.

As per the financials filed for FY 2024, the company reported a revenue of ₹162.38 Cr, a growth of 23% compared to the previous year. For the same year it recorded a net profit of ₹25.52 Cr (net margin 15.7%) and EBITDA of ₹37.66 Cr (EBITDA margin 23.2%). Revenue has grown at a compounded annual rate (CAGR) of 39% over three years and 46% over five years.

The company has about 41 employees on its provident fund (EPFO) records.

As per MCA filings, the company has open charges of ₹26.91 Cr and satisfied charges of ₹32.03 Cr on record. Court records list 5 cases involving the company, including 3 filed by the company and 2 filed against it; 1 case is pending. The company has 12 deals on record (7 secondary share transfers, 5 funding rounds), with disclosed funding of ₹9.69 Cr; the latest was in May 2021. Its 10 peer companies in the Pharma industry (API Manufacturers) are compared by revenue, 5 larger and 5 smaller; the largest is Srini Pharmaceuticals Private Limited with revenue of ₹165.56 Cr.

The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website synthochirals.com.

Company Details of Syntho Chirals Private Limited
CIN U24239TG2004PTC043066
Registration Number 043066
Incorporation Date 15 April 2004
ROC Hyderabad
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2024
Date of Balance Sheet 31 March 2024
Compliance Status Active Compliant
Key People
Sai Kiran Reddy Ragi Managing Director Cheemarla Vijaya Bhaskar Reddy Director Anitha Reddy Ragi Director
Contact Details
  • Email
    Locked
  • Telephone
    Locked
  • Website
    synthochirals.com
  • Social Media
    Locked
  • Registered Address
    66/B Phase – II Ida Mallapur, Hyderabad, Telangana, India – 500076
  • Industry
    Pharma, API Manufacturers
Comprehensive company report
Syntho Chirals Private Limited - one report that includes everything
  • Company details, directors and signatories
  • Historical financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Legal cases, compliance and MCA filings
  • One PDF report, delivered after checkout
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included

Unlock the full Syntho Chirals Private Limited report

Financials, compliance, directors, charges, ownership and filings for Syntho Chirals Private Limited in one report.

Financials from 2015 Directors & ownership Charges & compliance

Business Activity of Syntho Chirals Private Limited

The main business activity of Syntho Chirals is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.

Main Activity Group CodeDescription of Main ActivityBusiness Activity CodeDescription of Business ActivityTurnover Percentage
CManufacturingC6Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical productsLocked
Premium access

Business activity turnover details

Turnover share and past changes in activity are in the company report.

  • Turnover contribution
  • Historical classifications
  • Filing-level activity changes

Verified entity values are shown only after access is granted.

Financials of Syntho Chirals Private Limited FY 2024 filings available

Syntho Chirals Private Limited reported revenue of ₹162.38 Cr (up 23% YoY) for FY 2024.

Revenue · FY 2024
₹162.38 Cr ▲ 23%
Net profit · FY 2024
₹25.52 Cr margin 15.7%
EBITDA · FY 2024
₹37.66 Cr margin 23.2%

Compounded Annual Growth Rate (CAGR) of Syntho Chirals Private Limited

Revenue CAGR growth
1 year
▲ 23%
3 years · compounded
▲ 39%
5 years · compounded
▲ 46%
EBITDA CAGR growth
1 year
▲ 72%
3 years · compounded
▲ 107%
5 years · compounded
▲ 68%

Revenue has grown at a compounded annual rate (CAGR) of 46% over five years, including 23% growth in the latest year. EBITDA rose 72% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.

Financial Statement Summary of Syntho Chirals Private Limited

MetricsFY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Profit and Loss Statement
Revenue from Operations••••••••••••••••••••
Other Income••••••••••••••••••••
Total Revenue••••••••••••••••••••
Cost of Materials Consumed••••••••••••••••••••
Employee Benefit Expense••••••••••••••••••••
Finance Costs••••••••••••••••••••
Depreciation and Amortisation••••••••••••••••••••
Other Expenses••••••••••••••••••••
Total Expenses••••••••••••••••••••
EBITDA₹37.66 Cr••••••••••••••••
Profit Before Tax••••••••••••••••••••
Tax Expense••••••••••••••••••••
Net Profit (PAT)₹25.52 Cr••••••••••••••••
Balance Sheet
Share Capital••••••••••••••••••••
Reserves and Surplus••••••••••••••••••••
Net Worth (Total Equity)••••••••••••••••••••
Long-term Borrowings••••••••••••••••••••
Short-term Borrowings••••••••••••••••••••
Trade Payables••••••••••••••••••••
Total Liabilities••••••••••••••••••••
Fixed Assets••••••••••••••••••••
Investments••••••••••••••••••••
Inventories••••••••••••••••••••
Trade Receivables••••••••••••••••••••
Cash and Bank Balance••••••••••••••••••••
Total Assets••••••••••••••••••••

Financial Ratios of Syntho Chirals Private Limited

MetricsFY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Profitability
EBITDA Margin23.2%••••••••••••••••
Net Profit Margin15.7%••••••••••••••••
Return on Equity (ROE)••••••••••••••••••••
Return on Capital Employed (ROCE)••••••••••••••••••••
Return on Assets (ROA)••••••••••••••••••••
Liquidity and Debt
Current Ratio••••••••••••••••••••
Quick Ratio••••••••••••••••••••
Debt-to-Equity Ratio••••••••••••••••••••
Interest Coverage Ratio••••••••••••••••••••
Efficiency and Growth
Asset Turnover••••••••••••••••••••
Receivable Days••••••••••••••••••••
Payable Days••••••••••••••••••••
Inventory Days••••••••••••••••••••
Revenue Growth••••••••••••••••••••
Net Profit Growth••••••••••••••••••••

Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Syntho Chirals are in the company report.

Premium access

Financial statements from 2015

Earlier years and trend charts are in the company report.

  • Income statements
  • Balance sheets
  • Cash-flow statements
  • Ratios and benchmarks

Verified entity values are shown only after access is granted.

Peer Comparison of Syntho Chirals Private Limited

Syntho Chirals Private Limited is compared with the companies closest to it by revenue in the Pharma industry (API Manufacturers). Net profit, margin and employee counts of each company are in the company report.

CompanyRevenueNet profitMarginGrowth (1 yr)EmployeesLocation
Srini Pharmaceuticals Private Limited₹165.56 Cr (FY 2024)••••••••-18.0%••••Hyderabad, Telangana, India
Chromo Laboratories India Private Limited₹164.91 Cr (FY 2025)••••••••-6.0%••••Patancheru, Telangana, India
Calyx Chemicals and Pharmaceuticals Limited₹163.62 Cr (FY 2024)••••••••-21.0%••••Thane, Maharashtra, India
S.V. Labs Private Limited₹162.99 Cr (FY 2025)••••••••0.0%••••Hyderabad, Telangana, India
Vasista Life Sciences Private Limited₹162.88 Cr (FY 2025)••••••••19.0%••••Hyderabad, Telangana, India
Syntho Chirals Private Limited this company₹162.38 Cr (FY 2024)••••••••23.0%••••Hyderabad, Telangana, India
Vivin Drugs & Pharmaceuticals Private Limited₹161.52 Cr (FY 2023)••••••••-25.0%••••Hyderabad, Telangana, India
Valentis Laboratories Private Limited₹160.96 Cr (FY 2025)••••••••135.0%••••Sangareddy, Telangana, India
Everest Organics Limited Listed₹160.17 Cr (FY 2025)••••••••-19.0%••••Medak, Telangana, India
Vision Drugs Private Limited₹159.84 Cr (FY 2024)••••••••12.0%••••Hyderabad, Telangana, India
Infinium Pharmachem Limited₹157.83 Cr (FY 2025)••••••••15.0%••••Sojitra, Gujarat, India

Peers are the five companies nearest above and the five nearest below Syntho Chirals by revenue in the Pharma industry (API Manufacturers), from the latest filed financials of each company. Net profit, margin and employee counts of each peer are in the company report.

Auditor Details of Syntho Chirals Private Limited

Syntho Chirals Private Limited is audited by SAMPATH & RAMESH for the financial year 2023.

NameStatusAppointment DateCessation Date
SAMPATH & RAMESHLockedLockedLocked
Premium access

Complete auditor history

Appointment and cessation dates and past auditor changes are in the company report.

  • Appointment status
  • Appointment dates
  • Cessation dates
  • Auditor changes

Verified entity values are shown only after access is granted.

Board of Directors of Syntho Chirals Private Limited

Syntho Chirals has 7 current directors and 8 former directors. Current directors are listed first, with their designation and appointment date.

Current Directors
NameDesignationAppointment DateTenureStatus
Cheemarla Vijaya Bhaskar Reddy
Also directs: Basl Biopharma LLP, Vaidhatru Pharma Private Limited, Saas Pharma Chem Private Limited
Director22 Jun 20179 Years 3 MonthsCurrent
Anitha Reddy RagiDirector29 Mar 20188 Years 6 MonthsCurrent
Sai Kiran Reddy Ragi
Also directs: Basl Biopharma LLP, Vaidhatru Pharma Private Limited, Synthovelzen Pharma Private Limited and 1 more
Managing Director16 Feb 20233 Years 8 MonthsCurrent
Aruna Reddy RagiDirector29 Mar 20188 Years 6 MonthsCurrent
Ragi Bhuvanesh Reddy
Also directs: Basl Biopharma LLP, Synthovelzen Pharma Private Limited
Director12 Aug 20242 Years 2 MonthsCurrent
Sridhar Reddy Ragi
Also directs: Syntho Chirals Lifesciences Private Limited
Director16 Jun 200521 Years 4 MonthsCurrent
Showing 6 of 7 current directors. View all directors

Ownership and Shareholding of Syntho Chirals Private Limited

Premium access

Shareholding and ownership data

Promoter, institutional, public and beneficial ownership figures are in the company report.

  • Ownership categories
  • Historical changes
  • Group structure
  • FII and DII holdings

Verified entity values are shown only after access is granted.

Charges & Borrowings of Syntho Chirals Private Limited

Open charges
₹26.91 Cr
Satisfied charges
₹32.03 Cr
Breakdown by lending institutions
State Bank of India₹26.91 Cr
Latest charge details
DateLenderAmountStatus
11 Mar 2022State Bank of India₹25.96 CrOpen
01 Jun 2020State Bank of India₹95 LakhOpen
07 Jun 2021Axis Bank Limited₹25.9 CrSatisfied
29 Apr 2015Reliance Capital Ltd₹1.04 CrSatisfied
14 Jul 2007State Bank of India₹5.03 CrSatisfied

Total charge records: 6 View all charges

Deals & Funding of Syntho Chirals Private Limited

Syntho Chirals Private Limited has 12 deals on record (7 secondary share transfers, 5 funding rounds), with disclosed funding of ₹9.69 Cr; the latest was in May 2021.

Total deals
12
Secondary share transfers
7
Funding rounds
5
Disclosed funding
₹9.69 Cr

Deals on record (5 of 12)

WhenDealAmountParties
May 2021Funding round₹2.2 CrInvestors: 4 individuals
Mar 2020Secondary share transferUndisclosedBuyer: an individual
Seller: 2 individuals
Mar 2019Secondary share transferUndisclosedBuyer: 3 individuals
Seller: Escientia Biopharma Private Limited , an individual
Nov 2012Funding round₹2.42 CrInvestors: 2 individuals
Mar 2010Funding round₹58.5 LakhInvestors: Escientia Biopharma Private Limited , an individual
Premium access

Full deal history

All 12 deals with amounts, valuations, instruments and every party are in the company report.

  • Every funding round and share transfer
  • Amounts and valuations
  • Investors, buyers and sellers
  • Instruments and deal dates

Verified entity values are shown only after access is granted.

Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.

Employees and EPFO Compliance at Syntho Chirals Private Limited

Syntho Chirals Private Limited has a workforce of 41 employees as of Apr 06, 2024.

Employee count
41
Active EPFO establishments
1
Employee growth
-2.38%
Premium access

Employee and EPFO history

Monthly headcount, contribution history and filing status are in the company report.

  • Monthly headcount
  • PF contributions
  • ECR filing status
  • Establishment history

Verified entity values are shown only after access is granted.

CIN History of Syntho Chirals Private Limited

Syntho Chirals has one previous CIN (Corporate Identification Number): U24239AP2004PTC043066. The current CIN is U24239TG2004PTC043066, which is the unique identifier assigned by the Registrar of Companies.

CINStatus
U24239TG2004PTC043066Current
U24239AP2004PTC043066Previous

Recent Activity on Syntho Chirals Private Limited

Syntho Chirals Private Limited has 15 board changes on record since 2004: 7 appointments and 8 cessations. The latest: Ragi Bhuvanesh Reddy was appointed as Director on 12 Aug 2024.

AGM
Syntho Chirals Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records.
Appointed
Ragi Bhuvanesh Reddy was appointed as Director.
Ceased
Aruna Reddy Ragi ceased to be Managing Director.
Ceased
Linga Reddy Ragi ceased to be Managing Director.
Ceased
Sai Kiran Reddy Ragi ceased to be Director.
Filing
Syntho Chirals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Hyderabad.
Appointed
Sai Kiran Reddy Ragi was appointed as Managing Director.
Charges
A charge with State Bank Of India of Rs. 25.96 Cr registered on 11 Mar 2022 with Charge ID 100568035 was modified on 05 Jul 2022.
Charges
A charge registered on 07 Jun 2021 via Charge ID 100461506 with Axis Bank Limited was fully satisfied on 17 May 2022.
Charges
A charge with State Bank Of India amounted to Rs. 25.96 Cr with Charge ID 100568035 was registered on 11 Mar 2022.
Charges
A charge with Axis Bank Limited of Rs. 25.90 Cr registered on 07 Jun 2021 with Charge ID 100461506 was modified on 02 Aug 2021.
Charges
A charge registered on 14 Jul 2007 via Charge ID 10063271 with State Bank Of India was fully satisfied on 22 Jul 2021.

19 earlier events are listed in the company report.

Credit Ratings, Litigation & Regulatory Alerts for Syntho Chirals Private Limited

Premium access

Credit ratings, litigation, and regulatory alerts

Credit ratings, court records and regulatory alerts are in the company report.

  • Rating history
  • Court and tribunal cases
  • Regulatory alerts
  • Director-linked violations

Verified entity values are shown only after access is granted.

MSME Payment Delays by Syntho Chirals Private Limited

Premium access

MSME payment history

Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.

  • Outstanding amounts
  • Delay periods and reasons
  • MSME-1 filing history
  • Vendor payment signals

Verified entity values are shown only after access is granted.

Subsidiaries & Group Companies of Syntho Chirals Private Limited

Premium access

Corporate group structure

Parent, subsidiary, associate and joint venture records with holdings are in the company report.

  • Parent company
  • Subsidiaries and ownership
  • Associates and joint ventures
  • Entity investments

Verified entity values are shown only after access is granted.

GST Compliance of Syntho Chirals Private Limited

Syntho Chirals has 3 GST registrations: 2 active and 1 cancelled or inactive.

Total GSTINs
3
Active
2
Cancelled / inactive
1
GSTINStateStatusRegistered on
36AAICS0868B1ZFTelanganaActive01 Jul 2017
29AAICS0868B1ZAKarnatakaActive01 Jul 2017
Premium access

GST registrations and filing compliance

State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.

  • GSTIN registrations
  • State-wise filing status
  • HSN and SAC details
  • Tax jurisdiction records

Verified entity values are shown only after access is granted.

MCA Filings & Documents of Syntho Chirals Private Limited

Premium access

MCA filings and documents

Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.

  • Incorporation documents
  • Annual returns and statements
  • Charge filings
  • Complete filing index

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Syntho Chirals Private Limited

Syntho Chirals is an active private limited company based in Hyderabad, Telangana, India. The company works in api manufacturers, within the pharma industry. It was incorporated on 15 April 2004 (22+ years old) and is registered under CIN U24239TG2004PTC043066.

Syntho Chirals reported revenue of ₹162.38 Cr for FY 2024 (up 23% YoY).

Syntho Chirals has 7 current directors:

Syntho Chirals reported a net profit of ₹25.52 Cr (net margin 15.7%) and EBITDA of ₹37.66 Cr (EBITDA margin 23.2%) for FY 2024, as per its filed financial statements.

The compounded annual growth rate (CAGR) of the revenue of Syntho Chirals is 39% over three years and 46% over five years. In the latest year (FY 2024) revenue rose 23%. CAGR is the steady yearly rate that links the first and the last year.

The GSTIN of Syntho Chirals is 36AAICS0868B1ZF, registered in Telangana. The company has 3 GST registrations in all, of which 2 are active and 1 is cancelled or inactive. Other active GSTINs include 29AAICS0868B1ZA (Karnataka).

The CIN (Corporate Identification Number) of Syntho Chirals is U24239TG2004PTC043066. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.

Syntho Chirals has 5 court cases on record: 3 filed by the company and 2 filed against it. 1 is pending. Most are in the district courts.

Syntho Chirals was incorporated on 15 April 2004, making it 22+ years old. It is registered with the Registrar of Companies, Hyderabad.

Syntho Chirals has 12 deals on record (7 secondary share transfers, 5 funding rounds), with disclosed funding of ₹9.69 Cr; the latest was in May 2021.

The peers of Syntho Chirals by revenue are Srini Pharmaceuticals Private Limited, Chromo Laboratories India Private Limited, Calyx Chemicals and Pharmaceuticals Limited, S.V. Labs Private Limited, Vasista Life Sciences Private Limited and 5 more, all in the Pharma industry (API Manufacturers).

7M+ Indian companies. One platform.

Financials, directors, compliance, charges and shareholding - compiled from official filings and updated regularly.

Subscription plans available